Trademark: 79378146
Word
ORVYNZA
Status
Pending
Status Code
641
Status Date
Friday, March 29, 2024
Serial Number
79378146
Mark Type
4000
Filing Date
Tuesday, July 18, 2023

Trademark Owner History

Classifications
5 Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations for the prevention and treatment of diseases and disorders and of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections; pharmaceutical preparations for the prevention and treatment of oncological and auto-immune diseases and disorders; pharmaceutical preparations, namely, cell based immune therapeutics for treatment of cancer, for treatment of immunological diseases, and treatment of infectious diseases

Trademark Events
Mar 29, 2024
Non-Final Action Mailed - Refusal Sent To Ib
Mar 29, 2024
Refusal Processed By Mpu
Mar 12, 2024
Non-Final Action (Ib Refusal) Prepared For Review
Mar 11, 2024
Non-Final Action Written
Mar 9, 2024
Assigned To Examiner
Sep 19, 2023
Application Filing Receipt Mailed
Sep 15, 2023
New Application Office Supplied Data Entered
Sep 13, 2023
Limitation From Original Application Entered
Sep 7, 2023
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24